Cargando…
Encapsulation of Rat Bone Marrow Derived Mesenchymal Stem Cells in Alginate Dialdehyde/Gelatin Microbeads with and without Nanoscaled Bioactive Glass for In Vivo Bone Tissue Engineering
Alginate dialdehyde (ADA), gelatin, and nano-scaled bioactive glass (nBG) particles are being currently investigated for their potential use as three-dimensional scaffolding materials for bone tissue engineering. ADA and gelatin provide a three-dimensional scaffold with properties supporting cell ad...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213117/ https://www.ncbi.nlm.nih.gov/pubmed/30275427 http://dx.doi.org/10.3390/ma11101880 |
_version_ | 1783367696765681664 |
---|---|
author | Rottensteiner-Brandl, Ulrike Detsch, Rainer Sarker, Bapi Lingens, Lara Köhn, Katrin Kneser, Ulrich Bosserhoff, Anja K. Horch, Raymund E. Boccaccini, Aldo R. Arkudas, Andreas |
author_facet | Rottensteiner-Brandl, Ulrike Detsch, Rainer Sarker, Bapi Lingens, Lara Köhn, Katrin Kneser, Ulrich Bosserhoff, Anja K. Horch, Raymund E. Boccaccini, Aldo R. Arkudas, Andreas |
author_sort | Rottensteiner-Brandl, Ulrike |
collection | PubMed |
description | Alginate dialdehyde (ADA), gelatin, and nano-scaled bioactive glass (nBG) particles are being currently investigated for their potential use as three-dimensional scaffolding materials for bone tissue engineering. ADA and gelatin provide a three-dimensional scaffold with properties supporting cell adhesion and proliferation. Combined with nanocristalline BG, this composition closely mimics the mineral phase of bone. In the present study, rat bone marrow derived mesenchymal stem cells (MSCs), commonly used as an osteogenic cell source, were evaluated after encapsulation into ADA-gelatin hydrogel with and without nBG. High cell survival was found in vitro for up to 28 days with or without addition of nBG assessed by calcein staining, proving the cell-friendly encapsulation process. After subcutaneous implantation into rats, survival was assessed by DAPI/TUNEL fluorescence staining. Hematoxylin-eosin staining and immunohistochemical staining for the macrophage marker ED1 (CD68) and the endothelial cell marker lectin were used to evaluate immune reaction and vascularization. After in vivo implantation, high cell survival was found after 1 week, with a notable decrease after 4 weeks. Immune reaction was very mild, proving the biocompatibility of the material. Angiogenesis in implanted constructs was significantly improved by cell encapsulation, compared to cell-free beads, as the implanted MSCs were able to attract endothelial cells. Constructs with nBG showed higher numbers of vital MSCs and lectin positive endothelial cells, thus showing a higher degree of angiogenesis, although this difference was not significant. These results support the use of ADA/gelatin/nBG as a scaffold and of MSCs as a source of osteogenic cells for bone tissue engineering. Future studies should however improve long term cell survival and focus on differentiation potential of encapsulated cells in vivo. |
format | Online Article Text |
id | pubmed-6213117 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-62131172018-11-14 Encapsulation of Rat Bone Marrow Derived Mesenchymal Stem Cells in Alginate Dialdehyde/Gelatin Microbeads with and without Nanoscaled Bioactive Glass for In Vivo Bone Tissue Engineering Rottensteiner-Brandl, Ulrike Detsch, Rainer Sarker, Bapi Lingens, Lara Köhn, Katrin Kneser, Ulrich Bosserhoff, Anja K. Horch, Raymund E. Boccaccini, Aldo R. Arkudas, Andreas Materials (Basel) Article Alginate dialdehyde (ADA), gelatin, and nano-scaled bioactive glass (nBG) particles are being currently investigated for their potential use as three-dimensional scaffolding materials for bone tissue engineering. ADA and gelatin provide a three-dimensional scaffold with properties supporting cell adhesion and proliferation. Combined with nanocristalline BG, this composition closely mimics the mineral phase of bone. In the present study, rat bone marrow derived mesenchymal stem cells (MSCs), commonly used as an osteogenic cell source, were evaluated after encapsulation into ADA-gelatin hydrogel with and without nBG. High cell survival was found in vitro for up to 28 days with or without addition of nBG assessed by calcein staining, proving the cell-friendly encapsulation process. After subcutaneous implantation into rats, survival was assessed by DAPI/TUNEL fluorescence staining. Hematoxylin-eosin staining and immunohistochemical staining for the macrophage marker ED1 (CD68) and the endothelial cell marker lectin were used to evaluate immune reaction and vascularization. After in vivo implantation, high cell survival was found after 1 week, with a notable decrease after 4 weeks. Immune reaction was very mild, proving the biocompatibility of the material. Angiogenesis in implanted constructs was significantly improved by cell encapsulation, compared to cell-free beads, as the implanted MSCs were able to attract endothelial cells. Constructs with nBG showed higher numbers of vital MSCs and lectin positive endothelial cells, thus showing a higher degree of angiogenesis, although this difference was not significant. These results support the use of ADA/gelatin/nBG as a scaffold and of MSCs as a source of osteogenic cells for bone tissue engineering. Future studies should however improve long term cell survival and focus on differentiation potential of encapsulated cells in vivo. MDPI 2018-10-01 /pmc/articles/PMC6213117/ /pubmed/30275427 http://dx.doi.org/10.3390/ma11101880 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Rottensteiner-Brandl, Ulrike Detsch, Rainer Sarker, Bapi Lingens, Lara Köhn, Katrin Kneser, Ulrich Bosserhoff, Anja K. Horch, Raymund E. Boccaccini, Aldo R. Arkudas, Andreas Encapsulation of Rat Bone Marrow Derived Mesenchymal Stem Cells in Alginate Dialdehyde/Gelatin Microbeads with and without Nanoscaled Bioactive Glass for In Vivo Bone Tissue Engineering |
title | Encapsulation of Rat Bone Marrow Derived Mesenchymal Stem Cells in Alginate Dialdehyde/Gelatin Microbeads with and without Nanoscaled Bioactive Glass for In Vivo Bone Tissue Engineering |
title_full | Encapsulation of Rat Bone Marrow Derived Mesenchymal Stem Cells in Alginate Dialdehyde/Gelatin Microbeads with and without Nanoscaled Bioactive Glass for In Vivo Bone Tissue Engineering |
title_fullStr | Encapsulation of Rat Bone Marrow Derived Mesenchymal Stem Cells in Alginate Dialdehyde/Gelatin Microbeads with and without Nanoscaled Bioactive Glass for In Vivo Bone Tissue Engineering |
title_full_unstemmed | Encapsulation of Rat Bone Marrow Derived Mesenchymal Stem Cells in Alginate Dialdehyde/Gelatin Microbeads with and without Nanoscaled Bioactive Glass for In Vivo Bone Tissue Engineering |
title_short | Encapsulation of Rat Bone Marrow Derived Mesenchymal Stem Cells in Alginate Dialdehyde/Gelatin Microbeads with and without Nanoscaled Bioactive Glass for In Vivo Bone Tissue Engineering |
title_sort | encapsulation of rat bone marrow derived mesenchymal stem cells in alginate dialdehyde/gelatin microbeads with and without nanoscaled bioactive glass for in vivo bone tissue engineering |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213117/ https://www.ncbi.nlm.nih.gov/pubmed/30275427 http://dx.doi.org/10.3390/ma11101880 |
work_keys_str_mv | AT rottensteinerbrandlulrike encapsulationofratbonemarrowderivedmesenchymalstemcellsinalginatedialdehydegelatinmicrobeadswithandwithoutnanoscaledbioactiveglassforinvivobonetissueengineering AT detschrainer encapsulationofratbonemarrowderivedmesenchymalstemcellsinalginatedialdehydegelatinmicrobeadswithandwithoutnanoscaledbioactiveglassforinvivobonetissueengineering AT sarkerbapi encapsulationofratbonemarrowderivedmesenchymalstemcellsinalginatedialdehydegelatinmicrobeadswithandwithoutnanoscaledbioactiveglassforinvivobonetissueengineering AT lingenslara encapsulationofratbonemarrowderivedmesenchymalstemcellsinalginatedialdehydegelatinmicrobeadswithandwithoutnanoscaledbioactiveglassforinvivobonetissueengineering AT kohnkatrin encapsulationofratbonemarrowderivedmesenchymalstemcellsinalginatedialdehydegelatinmicrobeadswithandwithoutnanoscaledbioactiveglassforinvivobonetissueengineering AT kneserulrich encapsulationofratbonemarrowderivedmesenchymalstemcellsinalginatedialdehydegelatinmicrobeadswithandwithoutnanoscaledbioactiveglassforinvivobonetissueengineering AT bosserhoffanjak encapsulationofratbonemarrowderivedmesenchymalstemcellsinalginatedialdehydegelatinmicrobeadswithandwithoutnanoscaledbioactiveglassforinvivobonetissueengineering AT horchraymunde encapsulationofratbonemarrowderivedmesenchymalstemcellsinalginatedialdehydegelatinmicrobeadswithandwithoutnanoscaledbioactiveglassforinvivobonetissueengineering AT boccaccinialdor encapsulationofratbonemarrowderivedmesenchymalstemcellsinalginatedialdehydegelatinmicrobeadswithandwithoutnanoscaledbioactiveglassforinvivobonetissueengineering AT arkudasandreas encapsulationofratbonemarrowderivedmesenchymalstemcellsinalginatedialdehydegelatinmicrobeadswithandwithoutnanoscaledbioactiveglassforinvivobonetissueengineering |